Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Increases By 5.9%

Aurora Cannabis Inc. (NASDAQ:ACB) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 4,520,000 shares, an increase of 5.9% from the December 15th total of 4,270,000 shares. Approximately 8.3% of the shares of the company are short sold. Based on an average daily volume of 930,400 shares, the short-interest ratio is presently 4.9 days.

Aurora Cannabis Stock Down 2.8 %

Shares of NASDAQ ACB opened at $3.85 on Friday. The stock has a market cap of $211.29 million, a PE ratio of -5.07 and a beta of 1.86. The business has a fifty day moving average of $4.35 and a two-hundred day moving average of $5.31. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Cubist Systematic Strategies LLC bought a new position in shares of Aurora Cannabis in the second quarter valued at about $50,000. Toronto Dominion Bank raised its holdings in shares of Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after buying an additional 18,896 shares during the last quarter. Mackenzie Financial Corp bought a new position in shares of Aurora Cannabis in the second quarter valued at about $113,000. Finally, Tidal Investments LLC raised its holdings in shares of Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after buying an additional 34,988 shares during the last quarter. 47.63% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ACB shares. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. TD Cowen started coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They issued a “buy” rating on the stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.